Rheumatoid Arthritis Treatment in Katy, TX

Meet Dr. Syed Alam, MD, FACR

Double Board-Certified, Fellowship-Trained Rheumatologist · Musculoskeletal Ultrasound Trained · 10+ Years of Experience

Dr. Alam completed his rheumatology fellowship at Temple University Hospital after an internal medicine residency at John H. Stroger, Jr. Hospital. His clinical interests include rheumatoid arthritis, lupus, psoriatic arthritis, gout, Sjögren’s disease, osteoporosis and other rheumatic conditions.

Read the full profile →

What treat-to-target means

Rheumatoid arthritis treatment changed fundamentally about two decades ago. The old approach was to start a medicine, see how the patient got on, and escalate only when things clearly deteriorated. The current approach sets a defined target, measures against it at regular intervals, and changes treatment whenever the target is not met.

That target is remission: no swollen or tender joints, normal inflammation markers and minimal symptoms. Where remission is not achievable, low disease activity is the fallback. The evidence that this approach produces better joint preservation and better function is strong and consistent.

How progress is measured

At each review your rheumatologist counts swollen and tender joints, checks inflammation markers, and asks how you rate your disease. These combine into a score. It sounds mechanical, but it prevents the slow drift of accepting partial control, which is the most common reason people end up with avoidable joint damage.

The window of opportunity

Joint erosion can begin within months of the first symptoms, and most damage occurs in the first two years. Treatment started within the first three to six months produces substantially better outcomes than the same treatment started a year later. This is why rheumatologists move quickly once the diagnosis is clear.

The main treatment options

Methotrexate

The usual first choice and still the most effective single agent for most people. It is taken once a week, by tablet or by injection, with folic acid on the other days to reduce side effects. It takes six to twelve weeks to reach full effect. Alcohol should be limited, and it must not be taken in pregnancy, so contraception is discussed before starting.

Other conventional DMARDs

Hydroxychloroquine, sulfasalazine and leflunomide are used alone in milder disease or combined with methotrexate. Hydroxychloroquine is well tolerated and requires a periodic eye check. Combination therapy is often more effective than any single agent.

Biologic medicines

When conventional DMARDs are not enough, biologics block specific molecules that drive inflammation. TNF inhibitors are the most established group. Others target interleukin-6, deplete B cells, or interrupt T cell activation. They are given by injection or infusion, and they have transformed outcomes in rheumatoid arthritis.

JAK inhibitors

Targeted synthetic drugs taken by mouth that block intracellular signalling. They work quickly and are an option where injections are unsuitable. Cardiovascular and clot risk are considered when choosing them, particularly in older patients or those with existing risk factors.

Steroids as a bridge

A short course of low-dose prednisone, or a steroid injection into a badly inflamed joint, settles symptoms within days while a slower-acting medicine takes hold. The intention is always to withdraw them, because long-term use affects bone, blood sugar, weight and infection risk.

Photo for illustration. Images do not depict patients of this practice.

Before treatment starts

A short amount of preparation makes the first months considerably safer and smoother.

• Baseline blood count, liver and kidney function
• Screening for hepatitis B and C, and for tuberculosis, before biologic treatment
• A chest X-ray in most cases
• A review of vaccinations, ideally bringing them up to date before starting, since live vaccines need care afterwards
• A discussion about pregnancy plans, because several of these medicines are unsafe in pregnancy and some require a washout period
• A conversation about alcohol, particularly with methotrexate

Ask for written information about what to do if you develop an infection, and make sure you know which symptoms warrant contacting the clinic rather than waiting for the next appointment.

Monitoring during treatment

Monitoring serves two purposes: confirming the treatment is working, and confirming it is safe.

Safety monitoring

Blood tests every two to four weeks when starting or increasing a dose, then typically every one to three months once stable. These check blood counts, liver and kidney function. Skipping them is the most common avoidable problem, because most of what is being looked for causes no symptoms until it is advanced.

Disease activity monitoring

Joint counts, inflammation markers and your own assessment at each review. Where the target is not being met, the dose is increased, another medicine is added, or the treatment is changed. Reviews are typically every one to three months until stable, then every three to six months.

What to report between appointments

• Fever, persistent cough, or any infection that is not settling
• Mouth ulcers, unusual bruising or bleeding
• Yellowing of the skin or eyes
• Breathlessness or a new dry cough
• A flare that is not settling within a few days
• Pregnancy, or plans to conceive

What treatment does not do on its own

Medication controls the inflammation. Several other things determine how well you actually function, and they are worth as much attention.

• Stopping smoking. It worsens rheumatoid arthritis, reduces how well treatment works, and raises cardiovascular risk.
• Regular low-impact exercise to maintain strength and range of movement.
• Cardiovascular risk management, since long-term inflammation raises heart disease risk independently.
• Bone protection, particularly for anyone on steroids.
• Joint protection techniques for the hands: wider grips, lever handles, pacing heavy tasks.
• Managing fatigue, which is a genuine symptom of the disease rather than a lack of effort.

PLACEHOLDER: confirm and describe any in-house services relevant here, such as infusion therapy, joint injections, on-site laboratory testing or physical therapy referral pathways.

If you reach remission

Reaching remission is the goal, and it raises a reasonable question: can treatment stop? The honest answer is usually no, but it can often be reduced.

Stopping treatment entirely leads to a flare in the majority of people, and a flare risks new joint damage. What is frequently possible, after a sustained period of remission, is a careful reduction: lowering the dose, spacing biologic injections further apart, or withdrawing one agent from a combination while continuing another. This is done gradually with close monitoring so that any loss of control is caught early.

Steroids are the exception. Those should be withdrawn as soon as the disease is controlled by other means, and staying on low-dose prednisone indefinitely because it feels easier is a trade most rheumatologists will work hard to avoid.

Starting treatment at our Katy clinic

If you have recently been diagnosed, treatment should start promptly rather than after a period of watching. If you have had rheumatoid arthritis for years and still have swollen joints, morning stiffness over an hour, or regular flares, your treatment is not reaching target and it is worth reviewing.

Bring your current medication list, recent blood results and any imaging. Being able to see what has already been tried, and at what dose, avoids repeating steps that did not work.

PLACEHOLDER: this page must be reviewed and approved by the physician before launch. Confirm that every treatment described here is one this practice actually provides, and add the reviewing physician's name and review date.